Brief: FDA to Convene Advisory Panel for Review of IceCure's De Novo Marketing Clearance Request for ProSense

Icecure Medical

04/06/2024 13:45

June 4 (Reuters) - Icecure Medical Ltd  ICCM.O :
    * FDA TO CONVENE ADVISORY PANEL FOR REVIEW OF ICECURE'S DE
NOVO
MARKETING CLEARANCE REQUEST FOR PROSENSE®, DECISION EXPECTED
EARLY 2025; ALIGNS WITH COMMERCIAL READINESS PLAN
    * ICECURE MEDICAL LTD: ADVISORY PANEL IS EXPECTED TO CONVENE
IN Q4
OF 2024, WITH AN FDA DECISION ON WHETHER TO APPROVE PROSENSE®
EXPECTED BY EARLY 2025

Source text for Eikon:  ID:nPnWhq0Sa 
Further company coverage:  ICCM.O 

 ((Reuters.Briefs@thomsonreuters.com;))